Alpha Sense BI

APRIL 29, 2024

Heading into the second half of 2024, venture capital investors remain cautious as they acknowledge persistent challenging dynamics in the landscape. While dry powder reserves have reached record highs, investors are wary about deploying capital with certain recent macroeconomic factors still fresh in mind.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. As we navigate 2024, the landscape appears positioned for a triumphant comeback. Over the past few years, the technology industry has experienced dramatic highs and lows.

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

MARCH 28, 2023

The Value: AlphaSense is an AI-powered search engine for market intelligence. And with Stream in AlphaSense, users can leverage expert perspectives against insights derived from our extensive and ever-growing universe of content, gaining a 360 view on any market, industry, or trend.

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52